BICYCLE THERAPEUTICS PLC - Common Stock (BCYC)
CUSIP: 088786108
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,984,905
- Total 13F shares
- 12,412,613
- Share change
- +991,530
- Total reported value
- $376,901,461
- Price per share
- $30.36
- Number of holders
- 53
- Value change
- +$30,169,498
- Number of buys
- 32
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3.9%
|
1,957,961
|
$58,484,000 | — | 31 Mar 2021 | |
| SV Health Investors, LLC |
13F
|
Company |
3.8%
|
1,915,274
|
$57,209,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.4%
|
1,693,658
|
$50,654,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.2%
|
1,577,493
|
$47,120,000 | — | 31 Mar 2021 | |
| Logos Global Management LP |
13F
|
Company |
1.6%
|
800,000
|
$23,896,000 | — | 31 Mar 2021 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
1.2%
|
612,696
|
$18,301,000 | — | 31 Mar 2021 | |
| FIL Ltd |
13F
|
Company |
1%
|
523,201
|
$15,628,000 | — | 31 Mar 2021 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.88%
|
437,728
|
$13,076,000 | — | 31 Mar 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
411,838
|
$12,302,000 | — | 31 Mar 2021 | |
| Verition Fund Management LLC |
13F
|
Company |
0.48%
|
240,134
|
$7,173,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
0.42%
|
211,444
|
$6,316,000 | — | 31 Mar 2021 | |
| AXA S.A. |
13F
|
Company |
0.4%
|
197,799
|
$5,908,000 | — | 31 Mar 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.36%
|
179,992
|
$5,376,000 | — | 31 Mar 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.3%
|
150,000
|
$4,481,000 | — | 31 Mar 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.18%
|
91,640
|
$2,737,000 | — | 31 Mar 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.15%
|
75,454
|
$2,254,000 | — | 31 Mar 2021 | |
| MOODY ALDRICH PARTNERS LLC |
13F
|
Company |
0.15%
|
74,060
|
$2,212,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.12%
|
57,892
|
$1,729,000 | — | 31 Mar 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.08%
|
38,460
|
$1,148,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
26,800
|
$801,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.04%
|
21,917
|
$655,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
20,500
|
$612,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
18,300
|
$547,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
15,627
|
$467,000 | — | 31 Mar 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
12,574
|
$376,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
12,150
|
$363,000 | — | 31 Mar 2021 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.02%
|
12,000
|
$358,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
11,100
|
$331,000 | — | 31 Mar 2021 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.02%
|
9,908
|
$295,000 | — | 31 Mar 2021 | |
| KBC Group NV |
13F
|
Company |
0.01%
|
3,750
|
$112,000 | — | 31 Mar 2021 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.01%
|
3,260
|
$97,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,240
|
$67,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,302
|
$39,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,063
|
$31,000 | — | 31 Mar 2021 | |
| Eudaimonia Partners, LLC |
13F
|
Company |
0%
|
515
|
$15,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
513
|
$15,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
352
|
$11,000 | — | 31 Mar 2021 | |
| Evolution Wealth Advisors, LLC |
13F
|
Company |
0%
|
265
|
$8,000 | — | 31 Mar 2021 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
40
|
$1,000 | — | 31 Mar 2021 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) as of Q2 2021
As of 30 Jun 2021,
BICYCLE THERAPEUTICS PLC - Common Stock (BCYC) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,412,613 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, Logos Global Management LP, FIL Ltd, SAMLYN CAPITAL, LLC, Atlas Venture Advisors, Inc., and Verition Fund Management LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
39
Q2 2021 holders
53
Holder diff
14
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.